Tenants are increasingly looking for a “third space” where they can work away from both home and the office but are still close by.
Continue readingCategory Archives: Uncategorized
Disney wants sports leagues as ESPN partners, but it’s not clear sports leagues want ESPN
Partnering with sports leagues on ESPN may make sense for Disney, but it’s not yet clear it makes sense for the leagues.
Continue readingCustom art, air purifiers and TikTok: College-spending boom could booster retailers’ sales this fall
College students and their families are expected to spend more this year as demand for electronics and dorm decor grows.
Continue readingNovo Nordisk to acquire obesity drug maker Inversago Pharma for up to $1 billion
Inversago’s drugs use a different approach than most treatments in the obesity and diabetes space.
Continue readingVirgin Galactic launches first tourist flight to space
Virgin Galactic flew its second commercial spaceflight Thursday, its first carrying private-paying tourists.
Continue readingAirlines add flights to get travelers off of Maui after deadly wildfires
Airlines waived flight-change costs because of the deadly fires in the popular resort area of Maui in Hawaii.
Continue readingThe average Manhattan rent just hit a new record of $5,588 a month
Rents in Manhattan hit a new high in July, as higher interest rates and low supply continued to drive up prices.
Continue readingCoach owner Tapestry to acquire Michael Kors, Jimmy Choo parent Capri Holdings for $8.5 billion
The deal would create an American fashion giant that brings Coach, Kate Spade, Stuart Weitzman, Versace, Jimmy Choo and Michael Kors under one house.
Continue readingRetailers say organized theft is biting into profits, but internal issues may really be to blame
Target and Foot Locker may be using organized retail theft as a convenient excuse to cloak internal flaws, as others focus on internal theft and […]
Continue readingInsurers face long road, high cost to cover obesity drugs after promising Wegovy heart-health data
There is likely a long way to go before the U.S. sees increased insurance coverage of obesity drugs, but Novo Nordisk’s new data is a […]
Continue reading